Executive Leadership Team

David Allmond
Chief Executive Officer

  • Appointed CEO of Novacyt in 2021
  • Over 25 years of global experience in pharmaceuticals & biopharmaceutical companies
  • Internationally experienced, strategic business leader with strong track record in global commercialisation
  • Built & led multiple diverse, successful teams in dynamic growth companies including Amgen, Celgene & Amryt Pharma
  • C-level executive with AIM and NASDAQ listed companies

James McCarthy
Chief Financial Officer

  • Appointed CFO of Novacyt in 2021
  • Over 30 years in international manufacturing and industrial businesses in both consumer and B2B
  • CFO in both Private Equity and public businesses.
  • FCCA qualified over 30 years with broad commercial, supply chain and M&A experience

Navin Nauth-Misir
RA & QA Director

  • Joined Novacyt in May 2019
  • Over 30 years experience with medical devices and In Vitro Diagnostic medical devices
  • Experience in the NHS, regulatory authority and manufacturing companies
  • Extensive involvement in standards development and expert working groups
  • International regulatory expertise

Guillermo Raimondo
Chief Commercial Officer

  • Joined Novacyt in January 2021
  • Over 25 years in healthcare
  • Medical devices & services markets
  • Internationally experienced leader with multi-disciplinary background
  • Successful track record in driving customer facing organizations and different types and scale of business

Paul Oladimeji
Group Head of R&D

  • Joined Novacyt in May 2016
  • Over 10 years’ experience gained in neuroscience, molecular biology, applied research and diagnostics
  • Led the team that developed the world’s first COVID-19 test accredited for diagnostic testing in Europe
  • Proven track record of developing commercially viable products

David Franks 
Chief Human Resources Officer

  • Joined Novacyt in April 2021
  • 25 years corporate and advisory experience across a range of cultures and operating contexts
  • Track record of transformation and change, with a focus on scaling for growth and building organisational capability

Bryan Close
Chief Operations Officer

  • Joined Novacyt in January 2022
  • Chartered Engineer with over 35 years’ experience in Operations, Supply Chain and Project Management
  • 20 years working for a Global Blue Chip consumer goods manufacturer
  • 10 years in global pharmaceutical businesses
  • Responsible for Manufacturing & Supply Chain across Primer Design, Microgen & Lab 21